Original Research

Published on 05 Dec 2022

A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice

in Cytokines and Soluble Mediators in Immunity

Qianqian Ma
Xiaozhi Hu
Fangyu Liu
Zhonglian Cao
Lei Han
Kaicheng Zhou
Yu Bai
Yuting Zhang
Yanyang Nan
Qianying Lv

Frontiers in Immunology

doi 10.3389/fimmu.2022.1011442

3,878 views
4 citations

Mini Review

Published on 02 Dec 2022

Soluble mediators of innate immunity in annelids and bivalve mollusks: A mini-review

in Cytokines and Soluble Mediators in Immunity

Laura Canesi
Manon Auguste
Teresa Balbi
Petra Prochazkova

Frontiers in Immunology

doi 10.3389/fimmu.2022.1051155

2,815 views
11 citations

Systematic Review

Published on 30 Nov 2022

Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis

in Cytokines and Soluble Mediators in Immunity

Jie He
Jiangliu Zhang
Xinyi Ren

Frontiers in Immunology

doi 10.3389/fimmu.2022.1041098

3,706 views
5 citations

Editorial

Published on 29 Nov 2022

Editorial: Non-coding RNA in immunotherapies and immune regulation

in Cytokines and Soluble Mediators in Immunity

Bertrand Kaeffer
Chen Chen
Antoine Louveau

Frontiers in Immunology

doi 10.3389/fimmu.2022.1094643

1,484 views
1 citation

Original Research

Published on 25 Nov 2022

Knockout of IL-6 mitigates cold water-immersion restraint stress-induced intestinal epithelial injury and apoptosis

in Cytokines and Soluble Mediators in Immunity

Yuan Zhang
Chujun Duan
Shuwen Wu
Jingchang Ma
Yongming Liu
Wenpeng Li
Tingting Wang
Lu Yang
Kun Cheng
Ran Zhuang

Frontiers in Immunology

doi 10.3389/fimmu.2022.936689

2,498 views
4 citations

Original Research

Published on 24 Nov 2022

Determining distinct roles of IL-1α through generation of an IL-1α knockout mouse with no defect in IL-1β expression

in Cytokines and Soluble Mediators in Immunity

R.K. Subbarao Malireddi
Ratnakar R. Bynigeri
Balabhaskararao Kancharana
Bhesh Raj Sharma
Amanda R. Burton
Stephane Pelletier
Thirumala-Devi Kanneganti

Frontiers in Immunology

doi 10.3389/fimmu.2022.1068230

3,138 views
5 citations

Mini Review

Published on 22 Nov 2022

The osteoblast secretome in Staphylococcus aureus osteomyelitis

in Cytokines and Soluble Mediators in Immunity

Valentina Granata
Valentina Possetti
Raffaella Parente
Barbara Bottazzi
Antonio Inforzato
Cristina Sobacchi

Frontiers in Immunology

doi 10.3389/fimmu.2022.1048505

4,204 views
13 citations

Original Research

Published on 18 Nov 2022

Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage

in Cytokines and Soluble Mediators in Immunity

Nina Erdmann
Theresa Schilling
Julia Hentschel
Thomas Lehmann
Philipp von Bismarck
Tobias Ankermann
Franziska Duckstein
Michael Baier
Carlos Zagoya
Jochen G. Mainz

Frontiers in Immunology

doi 10.3389/fimmu.2022.947359

2,292 views
5 citations

Original Research

Published on 16 Nov 2022

Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease

in Cytokines and Soluble Mediators in Immunity

Xuanyan Cai
Huiyan Zha
Zhaoxu Yang
Yiwen Du
Xiaoyang Dai
Bo Yang
Jiajia Wang
Qiaojun He
Qinjie Weng

Frontiers in Immunology

doi 10.3389/fimmu.2022.1058532

1,829 views

Original Research

Published on 16 Nov 2022

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases

in Cytokines and Soluble Mediators in Immunity

Timothy J. Liu
Lynlee L. Lin
Erin McMeniman
Jason Wu
Yung-Ching Kao
Snehlata Kumari
Glen M. Boyle
James W. Wells
H. Peter Soyer
Jazmina L. Gonzalez-Cruz

Frontiers in Immunology

doi 10.3389/fimmu.2022.1028435

2,779 views
6 citations

Review

Published on 16 Nov 2022

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management

in Cytokines and Soluble Mediators in Immunity

Kai R. Plunkett
Jesse D. Armitage
Andrisha-Jade Inderjeeth
Alison M. McDonnell
Jason Waithman
Peter K. H. Lau

Frontiers in Immunology

doi 10.3389/fimmu.2022.1048758

5,225 views
7 citations

Review

Published on 14 Nov 2022

Platelet in thrombo-inflammation: Unraveling new therapeutic targets

in Cytokines and Soluble Mediators in Immunity

Swati Sharma
Tarun Tyagi
Silvio Antoniak

Frontiers in Immunology

doi 10.3389/fimmu.2022.1039843

10,534 views
33 citations

Original Research

Published on 14 Nov 2022

Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions

in Cytokines and Soluble Mediators in Immunity

Katharina M. Glaser
Teresa K. Tarrant
Tim Lämmermann

Frontiers in Immunology

doi 10.3389/fimmu.2022.1039803

2,938 views
2 citations

Original Research

Published on 14 Nov 2022

Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients

in Cytokines and Soluble Mediators in Immunity

Gabriela Profírio Jardim-Santos
Heidi Luise Schulte
Patricia Shu Kurizky
Ciro Martins Gomes
Otávio Tolêdo Nóbrega
Eliana Teles de Gois
Maíra Rocha Machado de Carvalho
Francielle Pulccinelli Martins
André Moraes Nicola
Cleandro Pires de Albuquerque

Frontiers in Immunology

doi 10.3389/fimmu.2022.1004023

2,113 views
3 citations

Original Research

Published on 03 Nov 2022

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis

in Cytokines and Soluble Mediators in Immunity

Javier Marín-Prida
Nancy Pavón-Fuentes
Nielsen Lagumersindez-Denis
Hanlet Camacho-Rodríguez
Ana Margarita García-Soca
Rocío de la Caridad Sarduy-Chávez
Érica Leandro Marciano Vieira
Juliana Carvalho-Tavares
Viviana Falcón-Cama
Julio Raúl Fernández-Massó

Frontiers in Immunology

doi 10.3389/fimmu.2022.1036200

4,890 views
10 citations

Mini Review

Published on 03 Nov 2022

The role of IL-38 in intestinal diseases - its potential as a therapeutic target

in Cytokines and Soluble Mediators in Immunity

Qiang Wang
Linna Ma
Caiping An
Steven G. Wise
Shisan Bao

Frontiers in Immunology

doi 10.3389/fimmu.2022.1051787

2,692 views
5 citations

Navigation group

Articles

A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice

Soluble mediators of innate immunity in annelids and bivalve mollusks: A mini-review

Krebs von den lungen-6 as a clinical marker for hypersensitivity pneumonitis: A meta-analysis and bioinformatics analysis

Editorial: Non-coding RNA in immunotherapies and immune regulation

Knockout of IL-6 mitigates cold water-immersion restraint stress-induced intestinal epithelial injury and apoptosis

Determining distinct roles of IL-1α through generation of an IL-1α knockout mouse with no defect in IL-1β expression

The osteoblast secretome in Staphylococcus aureus osteomyelitis

Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage

Genetic dominance of transforming growth factor-β1 polymorphisms in chronic liver disease

Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases

Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management

Platelet in thrombo-inflammation: Unraveling new therapeutic targets

Combinatorial depletions of G-protein coupled receptor kinases in immune cells identify pleiotropic and cell type-specific functions

Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis

The role of IL-38 in intestinal diseases - its potential as a therapeutic target